Barrington Strategic Wealth Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Barrington Strategic Wealth Management Group's ABBV Position: Q3 2017 in Review
Barrington Strategic Wealth Management Group reduced its AbbVie (ABBV) stake by 0.05% in Q3 2017, selling an estimated $381 and leaving 10,037 shares worth $892K. The position accounts for 0.45% of the portfolio, ranked #59.
Barrington Strategic Wealth Management Group first reported a position in ABBV in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.12M in Q2 2015. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.
- Barrington Strategic Wealth Management Group held 10,037 shares of AbbVie worth $892K as of Q3 2017.
- Barrington Strategic Wealth Management Group sold 5 AbbVie shares in Q3 2017, an estimated $381.
- AbbVie made up 0.45% of Barrington Strategic Wealth Management Group's portfolio in Q3 2017, its #59 holding.
- Barrington Strategic Wealth Management Group first reported a position in AbbVie in Q2 2013 and has held it in 18 quarters since.
- Barrington Strategic Wealth Management Group's AbbVie position peaked at $1.12M in Q2 2015.
- 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.
Based on Barrington Strategic Wealth Management Group's 13F filing for Q3 2017, filed 31 Oct 2017.